Literature DB >> 4171043

A clinico-immunological study of serum and synovial fluid antinuclear factors in rheumatoid arthritis and other arthritides.

R N MacSween, T G Dalakos, M K Jasani, J A Boyle, W W Buchanan, R B Goudie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4171043      PMCID: PMC1578893     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  14 in total

1.  THE ASSOCIATION OF RHEUMATOID FACTOR WITHANTINUCLEAR FACTOR ACTIVITY.

Authors:  J N MCCORMICK; J DAY
Journal:  Lancet       Date:  1963-09-14       Impact factor: 79.321

2.  Variations in the morphological patterns of "autoimmune" nuclear fluorescence.

Authors:  J S BECK
Journal:  Lancet       Date:  1961-06-03       Impact factor: 79.321

3.  A clinical study of serum antinuclear factor.

Authors:  D M WEIR; E J HOLBOROW; G D JOHNSON
Journal:  Br Med J       Date:  1961-04-01

4.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

5.  The relations between the antinuclear, rheumatoid and L.E.-cell factors in the systemic rheumatic diseases.

Authors:  A P HALL; W A BARDAWIL; T B BAYLES; A D MEDNIS; N GALINS
Journal:  N Engl J Med       Date:  1960-10-20       Impact factor: 91.245

6.  The significance of the lupus globulin; nucleoprotein reaction.

Authors:  G J FRIOU
Journal:  Ann Intern Med       Date:  1958-10       Impact factor: 25.391

7.  Dissociation of human serum macroglobulins.

Authors:  H F DEUTSCH; J I MORTON
Journal:  Science       Date:  1957-03-29       Impact factor: 47.728

8.  Antinuclear factors in synovial fluids.

Authors:  R N MacSween; T K Dalakos; M K Jasani; M E Wilson; J A Boyle; W W Buchanan; R B Goudie
Journal:  Lancet       Date:  1967-02-11       Impact factor: 79.321

9.  Antinuclear factors in synovia. Possible participants in the rheumatoid inclusion body.

Authors:  E V Barnett; J Bienenstock; K J Bloch
Journal:  JAMA       Date:  1966-10-10       Impact factor: 56.272

10.  The significance of antinuclear factors in rheumatoid arthritis.

Authors:  J J Condemi; E V Barnett; E C Atwater; R F Jacox; E S Mongan; J H Vaughan
Journal:  Arthritis Rheum       Date:  1965-12
View more
  3 in total

1.  Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis.

Authors:  A Wiik; E Jensen; J Friis
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

2.  Antinuclear factors and chronic articular inflammation.

Authors:  N J Zvaifler; M M Martinez
Journal:  Clin Exp Immunol       Date:  1971-02       Impact factor: 4.330

3.  Anti-Sm and anti-DNA antibodies in paired serum and synovial fluid samples from patients with SLE.

Authors:  K M Pollard; L J Furphy; J Webb
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.